，该应用还能向用户所参与医疗计划发送匿名数据包。如果用户没有连接设备，则可手工输入一些信息，或使用苹果iPhone 5s内置的M7协处理器来实现该目的。W&P移动开发团队，此前也负责开发了强生的7-Minute Workout应用。斯泰本透露，在Workout应用发布后的前四个月当中，其下载量已达到50万

(D1C7Y) XP® Rabbit mAbWB, IHC, IF, FH M R#59355Cathepsin B (D1C7Y) XP® Rabbit mAb (PE Conjugate)FH M R#55279Cathepsin B (D1C7Y) XP® Rabbit mAb (Alexa Fluor® 488

～22日地点：中国·南宁主办单位：中国医促会国际合作推广专业委员&nbsp...)决定2011年8月19～22日在南宁解放军303医院举办”泌尿男科学基础与临床研究进展暨第四届中日韩国际男科医师论坛(CJKAS2011

、氟伐他汀、阿托伐他汀、瑞舒代他汀以及匹伐他汀。本期问答：7 种他汀类药物的适应症存在何种差异？以上 7 种他汀类药物的药代动力学（半衰期长短、代谢五活性、排泄等）存在何种差异？哪些他汀类药物适合在晚餐时服用，各类他汀类药物对食物的影响如何？7 种他汀类药物，不同降脂水平所需药物剂量存在何种差异？洛伐他汀的适应症如何，其他的

http://v.qq.com/page/l/6/b/l07060x7c6b.html

医院和行业同仁的大力支持，在医疗质量与安全领域发挥了首倡者和推动者的作用，业已成为我国医疗质量管理的品牌盛会。2016 中国医院质量大会定于 9 月 20-22...地点1. 会议时间：2016 年 9 月 20-22 日9 月 20 日 全天报到9 月 21-22

美容设备、家用医疗康复保健器械等。（6）计生器械用品：B超、多普勒、监护设备，生化分析及试剂等。（7）口腔设备材料：牙科诊断设备、牙科.../9M2 外资企业1500美元/9 M2展位配置：提供三面围板、一张洽谈桌、两把椅子、两个射灯、一个插座

人类基因组在每次细胞分裂周期都会暴露于潜在有害的事件。DNA 复制和重组中的细胞新陈代谢或常规错误代表了潜在 DNA 损伤的内在来源。此外,接触外源基因毒性药物如电离辐射（IR）、紫外线（UV），氧化应激，化学诱变剂会导致核苷酸的修改和 DNA 单-和双链断裂。了解更多详情请查看>>

上。本研究为临床I期、开放式、多种剂量、交叉研究，旨在比较NVP XR 200mg、300mg和400mg剂量QD给药方案与NVP速释剂型（NVP IR...;18岁HIV-1患儿，该人群之前接受过为期超过18周NVP-IR为基础的治疗，并且病毒载量<50拷贝/毫升。对患儿按年龄进行分层研究，先给予NVP-IR

研究要点：高AGEs饮食增加胰岛素抵抗的发生；调整烹饪方法可减少AGEs含量，从而降低IR发生风险；摄入...模型评估胰岛素抵抗指数(HOMA-IR)和胰岛素敏感性指数。采用液相色谱串联质谱法测定食物和尿液中AGE浓度，以评估AGE吸收和排泄情况。 

（HOMA-IR）。该研究结果表明，总的来说，80%的PCOS受试者伴有临床明显的月经稀少。剩余的受试者显示阴道出血间隔＜35天（月经频繁或临床月经正常）。研究中仅有10%PCOS受试者排卵。校正BMI、年龄和种族后，所有PCOS受试者月经周期大于35天，平均HOMA-IR水平显著高于对照组，而且，月经周期大于3

：inivata.com02 液体活检的理论依据是什么？带有肿瘤组织基因突变信息的 ctDNA 由肿瘤细胞释放到血液中，液体活检能够检测到包含点突变（SNV）、短片段插入缺失...;2019, 25: 1415–1421.2.Lim C, Sung M, Shepherd FA, et al. Patients

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

生物药”的权限。　　7、诺华意欲进行更多收购　　瑞士诺华制药公司声称将进行更多收购来增加产品供应，或者直接收购开发医疗产品的公司。诺华最近刚刚购买... required) (07/12) Reuters (07/11)　　7) Novartis expresses interest in more

一文读懂

手术前后部分区域的代谢显著改变与治疗效果相关双侧前囊切开术治疗难治性强迫症的治疗获益可能是通过破坏皮质-纹状体-下丘脑-皮质通路。为了对这个问题进行深入研究，我国上海复旦大学附属华山医院的管一晖教授等人进行了一项研究，使用PET成像评估残存脑的代谢情况与强迫症患者的治疗效果。研究结果在线发表在2013年2月27日的Journal of Cerebral Blood Flow &amp; Metabolism杂志上。研究结果显示：患 ...